Triple
T5689057
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CLARITY AD |
E125383
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | Alzheimer’s disease clinical trial |
C18610
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: Alzheimer’s disease clinical trial Context triple: [CLARITY AD, instanceOf, Alzheimer’s disease clinical trial]
-
A.
Alzheimer’s disease drug
An Alzheimer’s disease drug is a pharmacological agent designed to prevent, slow, or alleviate the cognitive and functional decline associated with Alzheimer’s pathology, typically by targeting amyloid, tau, neurotransmitter systems, or related neurodegenerative mechanisms.
-
B.
National Institute on Aging program
A National Institute on Aging program is a coordinated set of research, funding, and outreach initiatives designed to advance scientific understanding of aging and improve the health and well-being of older adults.
-
C.
dementia
Dementia is a progressive cognitive disorder characterized by a decline in memory, thinking, behavior, and the ability to perform everyday activities severe enough to interfere with daily life.
-
D.
neurodegenerative disease
A neurodegenerative disease is a disorder characterized by the progressive loss of structure or function of neurons in the nervous system, often leading to cognitive, motor, and functional decline over time.
-
E.
disease-modifying therapy
A disease-modifying therapy is a treatment that alters the underlying course or mechanisms of a disease to slow its progression, reduce long-term damage, or change its overall outcome rather than just alleviating symptoms.
- F. None of above. chosen
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0082bb19c8190823a4facd3cba79b |
completed | March 22, 2026, 3:18 p.m. |
Created at: March 22, 2026, 3:44 p.m.